235 related articles for article (PubMed ID: 29165684)
1. Can Biomarkers Advance HIV Research and Care in the Antiretroviral Therapy Era?
Justice AC; Erlandson KM; Hunt PW; Landay A; Miotti P; Tracy RP
J Infect Dis; 2018 Jan; 217(4):521-528. PubMed ID: 29165684
[TBL] [Abstract][Full Text] [Related]
2. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
[TBL] [Abstract][Full Text] [Related]
3. Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral Therapy.
Angelidou K; Hunt PW; Landay AL; Wilson CC; Rodriguez B; Deeks SG; Bosch RJ; Lederman MM
J Infect Dis; 2018 Jun; 218(2):239-248. PubMed ID: 29309629
[TBL] [Abstract][Full Text] [Related]
4. Short Communication: Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
Brunt SJ; Cysique LA; Lee S; Burrows S; Brew BJ; Price P
AIDS Res Hum Retroviruses; 2016 Jun; 32(6):567-72. PubMed ID: 26876416
[TBL] [Abstract][Full Text] [Related]
5. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.
Freiberg MS; Bebu I; Tracy R; So-Armah K; Okulicz J; Ganesan A; Armstrong A; O'Bryan T; Rimland D; Justice AC; Agan BK;
PLoS One; 2016; 11(4):e0152588. PubMed ID: 27088215
[TBL] [Abstract][Full Text] [Related]
6. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
[TBL] [Abstract][Full Text] [Related]
7. HIV-related metabolic comorbidities in the current ART era.
Warriner AH; Burkholder GA; Overton ET
Infect Dis Clin North Am; 2014 Sep; 28(3):457-76. PubMed ID: 25151566
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.
Rubin LH; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Kisakye A; Batte J; Mayanja R; Anok A; Lofgren SM; Boulware DR; Dastgheyb R; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Sacktor N
J Neurovirol; 2019 Dec; 25(6):800-813. PubMed ID: 31218522
[TBL] [Abstract][Full Text] [Related]
9. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
Tenorio AR; Zheng Y; Bosch RJ; Krishnan S; Rodriguez B; Hunt PW; Plants J; Seth A; Wilson CC; Deeks SG; Lederman MM; Landay AL
J Infect Dis; 2014 Oct; 210(8):1248-59. PubMed ID: 24795473
[TBL] [Abstract][Full Text] [Related]
10. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
[TBL] [Abstract][Full Text] [Related]
12. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era.
Akgün KM; Tate JP; Pisani M; Fried T; Butt AA; Gibert CL; Huang L; Rodriguez-Barradas MC; Rimland D; Justice AC; Crothers K
Crit Care Med; 2013 Jun; 41(6):1458-67. PubMed ID: 23507717
[TBL] [Abstract][Full Text] [Related]
13. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
Taiwo B; Hicks C; Eron J
J Antimicrob Chemother; 2010 Jun; 65(6):1100-7. PubMed ID: 20348088
[TBL] [Abstract][Full Text] [Related]
14. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.
Montoya JL; Iudicello J; Fazeli PL; Hong S; Potter M; Ellis RJ; Grant I; Letendre SL; Moore DJ;
J Acquir Immune Defic Syndr; 2017 Feb; 74(2):134-141. PubMed ID: 27828873
[TBL] [Abstract][Full Text] [Related]
15. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.
Sanford R; Fernandez Cruz AL; Scott SC; Mayo NE; Fellows LK; Ances BM; Collins DL
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):563-570. PubMed ID: 28129254
[TBL] [Abstract][Full Text] [Related]
16. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy.
Wyatt CM; Klotman PE; D'Agati VD
Semin Nephrol; 2008 Nov; 28(6):513-22. PubMed ID: 19013322
[TBL] [Abstract][Full Text] [Related]
17. CROI 2016: Complications of HIV Infection and Antiretroviral Therapy.
Havlir DV; Currier JS
Top Antivir Med; 2016; 24(1):38-46. PubMed ID: 27398861
[TBL] [Abstract][Full Text] [Related]
18. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
Front Immunol; 2021; 12():738743. PubMed ID: 34630420
[TBL] [Abstract][Full Text] [Related]
19. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
[TBL] [Abstract][Full Text] [Related]
20. Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
Svicher V; Marchetti G; Ammassari A; Ceccherini-Silberstein F; Sarmati L;
AIDS Rev; 2017; 19(3):119-133. PubMed ID: 28926559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
